Liver impairment (0.1% incident) and Jaundice (unsure incident): Liver impairment and jaundice characterized by the increasing value of AST (GOT), ALT (GPT), γ GPT, and alkaline phosphatase has been reported in patients who received rebamipide tablet, if abnormal laboratory values is found, discontinue the drug and give the appropriate action.
Other side effects: Hypersensitivity: redness, itching and urticaria.
Neuropsychiatric: dizziness, drowsiness.
GI tract: constipation, abdomen enlargement.
Others: menstrual disturbances, BUN concentration increased, oedema and body and esophageal discomfort, breast pain and inflammation, gynecomastia, lactation induced, palpitation, fever, burning sensation on the face, numb feeling on the tongue, cough, respiratory disorders and alopecia.
View ADR Monitoring Form